Vardiman JW World Health Organization classification of tumours. Pathology and genetics, tumours of haematopoietic and lymphoid tissues, 2001. ,
Joab I Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus, Blood, vol.81, pp.2688-2695, 1993. ,
Barr virus in T and natural killer (NK) cell non-Hodgkin s lymphomas ', Leukemia, vol.10, issue.2, pp.84-87, 1996. ,
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials, Blood, vol.109, issue.5, pp.2183-2189, 2007. ,
DOI : 10.1182/blood-2006-07-033142
p53 Mutations in Nasal Natural Killer/T-Cell Lymphoma from Mexico, The American Journal of Pathology, vol.159, issue.6, pp.2095-2105, 2001. ,
DOI : 10.1016/S0002-9440(10)63061-1
Frequent mutations of Fas gene in nasal NK/T cell lymphoma, Oncogene, vol.21, issue.30, pp.4702-4705, 2002. ,
DOI : 10.1038/sj.onc.1205571
P53, N- and K-Ras, and ??-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan, Human Pathology, vol.35, issue.1, pp.86-95, 2004. ,
DOI : 10.1016/j.humpath.2003.08.025
Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma, Laboratory Investigation, vol.276, issue.7, pp.874-884, 2005. ,
DOI : 10.1038/labinvest.3700291
Nasal NK/T-cell lymphoma: epidemiology and pathogenesis, International Journal of Hematology, vol.108, issue.Suppl, pp.110-117, 2008. ,
DOI : 10.1007/s12185-008-0021-7
Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells, Cancer, vol.81, issue.11, pp.2351-2356, 1995. ,
DOI : 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1
A novel nude mice model of human extranodal nasal type NK/T-cell lymphoma, Leukemia, vol.12, issue.1, pp.170-178, 2008. ,
DOI : 10.1038/sj.leu.2404945
Akagi T Characterization of a novel human natural killer cell line (NK-YS) established from natural killer cell ? lymphoma/leukemia associated with Epstein-Barr virus infection, Blood, vol.92, pp.1374-1383, 1998. ,
Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3e+, CD56+ phenotype and associated with the Epstein-Barr virus, British Journal of Haematology, vol.98, issue.3, pp.669-677, 1998. ,
DOI : 10.1046/j.1365-2559.1996.278324.x
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation, Leukemia, vol.14, issue.5, pp.922-930, 2000. ,
DOI : 10.1038/sj.leu.2401769
Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus, Blood, vol.97, issue.3, pp.708-713, 2001. ,
DOI : 10.1182/blood.V97.3.708
Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia???lymphoma, Leukemia, vol.14, issue.5, pp.777-782, 2000. ,
DOI : 10.1038/sj.leu.2401778
Signal transducer and activator of transcription proteins in leukemias, Blood, vol.101, issue.8, pp.2940-2954, 2003. ,
DOI : 10.1182/blood-2002-04-1204
Stat3 as an Oncogene, Cell, vol.98, issue.3, pp.295-303, 1999. ,
DOI : 10.1016/S0092-8674(00)81959-5
URL : http://doi.org/10.1016/s0092-8674(00)81959-5
STATs in oncogenesis, Oncogene, vol.19, issue.21, pp.2474-2488, 2000. ,
DOI : 10.1038/sj.onc.1203527
What does Stat3 do?, Journal of Clinical Investigation, vol.109, issue.9, pp.1143-1148, 2002. ,
DOI : 10.1172/JCI0215650
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death, Oncogene, vol.21, issue.7, pp.1038-1047, 2002. ,
DOI : 10.1038/sj.onc.1205152
Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma, The Journal of Immunology, vol.168, issue.1, pp.466-474, 2002. ,
DOI : 10.4049/jimmunol.168.1.466
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target, Nature Medicine, vol.261, issue.6, pp.623-629, 2005. ,
DOI : 10.1084/jem.190.10.1451
Targeting Signal-Transducer-and-Activator-of-Transcription-3 for Prevention and Therapy of Cancer, Annals of the New York Academy of Sciences, vol.3, issue.6, pp.151-169, 2006. ,
DOI : 10.1196/annals.1378.063
Guidelines for the characterization and publication of human malignant hematopoietic cell lines, Leukemia, vol.13, issue.6, pp.835-842, 1999. ,
DOI : 10.1038/sj.leu.2401428
NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect, Blood, vol.105, issue.10, pp.4135-4142, 2005. ,
DOI : 10.1182/blood-2004-10-4113
Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation, Blood, vol.105, issue.6, pp.2608-2613, 2005. ,
DOI : 10.1182/blood-2004-04-1667
Stat3 activation in human endometrial and cervical cancers, British Journal of Cancer, vol.57, issue.4, pp.591-599, 2007. ,
DOI : 10.1126/science.8140422
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001. ,
DOI : 10.1006/meth.2001.1262
The biology of human natural killer-cell subsets, Trends in Immunology, vol.22, issue.11, pp.633-640, 2001. ,
DOI : 10.1016/S1471-4906(01)02060-9
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis, Oncogene, vol.21, issue.13, pp.2000-2008, 2002. ,
DOI : 10.1038/sj.onc.1205260
Specific Ablation of Stat3?? Distorts the Pattern of Stat3-Responsive Gene Expression and Impairs Recovery from Endotoxic Shock, Cell, vol.108, issue.3, pp.331-344, 2002. ,
DOI : 10.1016/S0092-8674(02)00636-0
Self-renewal of pluripotent embryonic stem cells is mediated via activation of??STAT3, Genes & Development, vol.12, issue.13, pp.2048-2060, 1998. ,
DOI : 10.1101/gad.12.13.2048
Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias, Blood, vol.109, issue.4, pp.1678-1686, 2007. ,
DOI : 10.1182/blood-2006-01-029918
Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation, Journal of Biological Chemistry, vol.276, issue.48 ,
DOI : 10.1074/jbc.M107527200
Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?, British Journal of Haematology, vol.20, issue.4, pp.539-548, 2007. ,
DOI : 10.1182/blood-2004-09-3502
URL : https://hal.archives-ouvertes.fr/hal-00451209
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder, Blood, vol.104, issue.3, pp.735-743, 2004. ,
DOI : 10.1182/blood-2003-10-3413
A novel member of the interferon receptor family complements functionality of the murine interferon ?? receptor in human cells, Cell, vol.76, issue.5, pp.803-810, 1994. ,
DOI : 10.1016/0092-8674(94)90355-7
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation, Cell, vol.82, issue.2, pp.241-250, 1995. ,
DOI : 10.1016/0092-8674(95)90311-9
Requirement of serine phosphorylation for formation of STAT-promoter complexes, Science, vol.267, issue.5206, pp.1990-1994, 1995. ,
DOI : 10.1126/science.7701321
STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes, Proceedings of the National Academy of Sciences, vol.102, issue.19, pp.6948-6953, 2005. ,
DOI : 10.1073/pnas.0501959102
STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes, Blood, vol.108, issue.3, pp.1058-1064, 2006. ,
DOI : 10.1182/blood-2005-08-007377
Tissue-Specific Autoregulation of the stat3 Gene and Its Role in Interleukin-6-Induced Survival Signals in T Cells, Molecular and Cellular Biology, vol.21, issue.19, pp.6615-6625, 2001. ,
DOI : 10.1128/MCB.21.19.6615-6625.2001
Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation, Cancer Res, vol.65, pp.939-947, 2005. ,
Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas, The American Journal of Pathology, vol.153, issue.4, pp.1229-1237, 1998. ,
DOI : 10.1016/S0002-9440(10)65667-2
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3, Proceedings of the National Academy of Sciences, vol.103, issue.26, pp.9964-9969, 2006. ,
DOI : 10.1073/pnas.0603507103
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nature Reviews Immunology, vol.172, issue.1, pp.41-51, 2007. ,
DOI : 10.1038/nri1995
Latent membrane protein 1of Epstein-Barr virus interacts with JAK3 and activates STAT proteins, The EMBO Journal, vol.18, issue.11 ,
DOI : 10.1093/emboj/18.11.3064
LMP1 structure and signal transduction, Seminars in Cancer Biology, vol.11, issue.6, pp.435-444, 2001. ,
DOI : 10.1006/scbi.2001.0410